Literature DB >> 9694826

Sequence-specific binding of Ku autoantigen to single-stranded DNA.

H Torrance1, W Giffin, D J Rodda, L Pope, R J Haché.   

Abstract

Glucocorticoid-induced transcription of mouse mammary tumor virus is repressed by Ku antigen/DNA-dependent protein kinase (DNA-PK) through a DNA sequence element (NRE1) in the viral long terminal repeat. Nuclear factors binding to the separated single strands of NRE1 have been identified that may also be important for transcriptional regulation through this element. We report the separation of the upper-stranded NRE1 binding activity in Jurkat T cell nuclear extracts into two components. One component was identified as Ku antigen. The DNA sequence preference for Ku binding to single-stranded DNA closely paralleled the sequence requirements of Ku for double-stranded DNA. Recombinant Ku bound the single, upper strand of NRE1 with an affinity that was 3-4-fold lower than its affinity for double-stranded NRE1. Sequence-specific single-stranded Ku binding occurred rapidly (t1/2 on = 2.0 min) and was exceptionally stable, with an off rate of t1/2= 68 min. While Ku70 cross-linked to the upper strand of NRE1 when Ku was bound to double-stranded and single-stranded DNAs, the Ku80 subunit only cross-linked to single-stranded NRE1. Intriguingly, addition of Mg2+ and ATP, the cofactors required for Ku helicase activity, induced the cross-linking of Ku80 to a double-stranded NRE1-containing oligonucleotide, without completely unwinding the two strands.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9694826     DOI: 10.1074/jbc.273.33.20810

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  8 in total

1.  Computational studies on full-length Ku70 with DNA duplexes: base interactions and a helical path.

Authors:  Shaowen Hu; Francis A Cucinotta
Journal:  J Mol Model       Date:  2011-08-26       Impact factor: 1.810

2.  Ku antigen-DNA conformation determines the activation of DNA-dependent protein kinase and DNA sequence-directed repression of mouse mammary tumor virus transcription.

Authors:  W Giffin; W Gong; C Schild-Poulter; R J Haché
Journal:  Mol Cell Biol       Date:  1999-06       Impact factor: 4.272

3.  Granzyme A, which causes single-stranded DNA damage, targets the double-strand break repair protein Ku70.

Authors:  Pengcheng Zhu; Dong Zhang; Dipanjan Chowdhury; Denis Martinvalet; Dennis Keefe; Lianfa Shi; Judy Lieberman
Journal:  EMBO Rep       Date:  2006-01-20       Impact factor: 8.807

4.  Cutting edge: Ku70 is a novel cytosolic DNA sensor that induces type III rather than type I IFN.

Authors:  Xing Zhang; Terrence W Brann; Ming Zhou; Jun Yang; Raphael M Oguariri; Kristy B Lidie; Hiromi Imamichi; Da-Wei Huang; Richard A Lempicki; Michael W Baseler; Timothy D Veenstra; Howard A Young; H Clifford Lane; Tomozumi Imamichi
Journal:  J Immunol       Date:  2011-03-11       Impact factor: 5.422

5.  OBA/Ku86: DNA binding specificity and involvement in mammalian DNA replication.

Authors:  M T Ruiz; D Matheos; G B Price; M Zannis-Hadjopoulos
Journal:  Mol Biol Cell       Date:  1999-03       Impact factor: 4.138

6.  DNA-dependent protein kinase (DNA-PK) phosphorylates nuclear DNA helicase II/RNA helicase A and hnRNP proteins in an RNA-dependent manner.

Authors:  Suisheng Zhang; Bernhard Schlott; Matthias Görlach; Frank Grosse
Journal:  Nucleic Acids Res       Date:  2004-01-02       Impact factor: 16.971

7.  Enhanced binding of poly(ADP-ribose)polymerase-1 and Ku80/70 to the ITGA2 promoter via an extended cytosine-adenosine repeat.

Authors:  Yann Cheli; Shirley A Williams; Robert Ballotti; Diane J Nugent; Thomas J Kunicki
Journal:  PLoS One       Date:  2010-01-15       Impact factor: 3.240

8.  DNA-PK contributes to the phosphorylation of AIRE: importance in transcriptional activity.

Authors:  Ingrid Liiv; Ana Rebane; Tõnis Org; Mario Saare; Julia Maslovskaja; Kai Kisand; Erkki Juronen; Leena Valmu; Matthew James Bottomley; Nisse Kalkkinen; Pärt Peterson
Journal:  Biochim Biophys Acta       Date:  2007-10-04
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.